Your session is about to expire
← Back to Search
Contrast EUS for Pancreatic Conditions
N/A
Recruiting
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must have unexplained pancreatitis, pancreas mass(es), or pancreatic cystic lesions (>1cm or worrisome features on imaging)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will study whether adding contrast to standard Endoscopic Ultrasound (EUS) improves the accuracy of diagnosing lesions and targeting biopsies in the pancreas.
Who is the study for?
This trial is for adults with unexplained pancreatitis, pancreatic masses, or cysts larger than 1cm or with concerning features. It's not for those under 18, pregnant or breastfeeding women, people with unstable heart disease, allergies to the contrast agent Definity, or certain heart shunts.Check my eligibility
What is being tested?
The study tests if adding a contrast agent to Endoscopic Ultrasound (EUS) improves diagnosis of pancreatic conditions. Participants will undergo standard EUS and then EUS enhanced with contrast to see if it better identifies lesions and guides biopsies.See study design
What are the potential side effects?
Potential side effects may include reactions to the contrast agent used in the procedure such as mild allergic symptoms. There's also a small risk of embolization due to cardiac shunts which is why patients with these conditions are excluded.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have unexplained pancreatitis or a suspicious mass or cyst in my pancreas.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The yield of EUS versus contrast EUS to diagnose pancreas cystic lesions, mass lesion, and origin of pancreatitis.
Secondary outcome measures
Quantitative Parameters of Pancreas Lesions
Targeting of FINE NEEDLE ASPIRATION (FNA) of pancreas lesions.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Contrast EUSExperimental Treatment1 Intervention
Undergoing EUS for pancreatic indication (cyst, pancreatitis, mass)
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,168 Total Patients Enrolled
9 Trials studying Pancreatitis
3,962 Patients Enrolled for Pancreatitis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are allergic to Definity.I do not have unstable heart disease.You have a certain type of heart condition that could pose a small risk during the study.I am scheduled for an endoscopic ultrasound for my pancreas.I have unexplained pancreatitis or a suspicious mass or cyst in my pancreas.I am over 18, not pregnant, and not breastfeeding.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Contrast EUS
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the maximum capacity for participants of this clinical experiment?
"Affirmative. As viewing from clinicaltrials.gov, this study is presently searching for participants. This trial was first listed on July 1st 2016 and most recently updated on December 6th 2021. The researchers are aiming to recruit 150 individuals across one site."
Answered by AI
To what demographic is this research study open?
"Individuals with a pancreatic cyst and aged between 18-99 are eligible to join this clinical trial, which is limited to 150 participants."
Answered by AI
Are there any vacancies available for participants in this clinical study?
"Clinicaltrials.gov confirms that this trial is currently in the process of enrolling study members, having first been advertised on July 1st 2016 and last updated December 6th 2021."
Answered by AI
Does this trial offer participation to individuals aged sixty and over?
"This medical study is only available to those aged 18-99 years old. There are seventeen studies for minors and six hundred sixty one trials catering specifically to seniors."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger